Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 2 | — | — | — | 2 |
Carcinoma | D002277 | — | C80.0 | 1 | 1 | — | — | — | 1 |
Mesothelioma | D008654 | — | C45 | 1 | 1 | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 1 | — | — | — | 1 |
Drug common name | RABUSERTIB |
INN | rabusertib |
Description | 1-[5-bromo-4-methyl-2-[[(2S)-2-morpholinyl]methoxy]phenyl]-3-(5-methyl-2-pyrazinyl)urea is a member of ureas. |
Classification | Small molecule |
Drug class | serine/threonine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1 |
PDB | — |
CAS-ID | 911222-45-2 |
RxCUI | — |
ChEMBL ID | CHEMBL3039517 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 3S9L1NU6U7 (ChemIDplus, GSRS) |